{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:53:36Z","timestamp":1787759616727,"version":"build-2784847793"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 AI148365-01A1"],"award-info":[{"award-number":["1R01 AI148365-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Invasive fungal infections in the United States are chronically underdiagnosed and a lack of coordinated surveillance makes the true burden of disease difficult to determine. The purpose of this analysis was to capture mortality-associated burden of risk conditions and fungal infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed data from the National Vital Statistics System from 1999 through 2018 to estimate the mortality attributed to risk conditions and related fungal disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The number of risk conditions associated with fungal disease is steadily rising in the United States, with 1 047 422 diagnoses at time of death in 2018. While fungal disease decreased substantially from 1999 to 2010, primarily due to the control of human immunodeficiency virus (HIV) infection, the number of deaths with fungal diagnosis has increased in the non-HIV cohort, with significant increases in patients with diabetes, cancer, immunosuppressive disorders, or sepsis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The landscape of individuals at risk for serious fungal diseases is changing, with a continued decline in HIV-associated incidence but increased diagnoses in patients with cancer, sepsis, immunosuppressive disorders, and influenza. Additionally, there is an overall increase in the number of fungal infections in recent years, indicating a failure to control fungal disease mortality in these new immunocompromised cohorts. Improvement in the prevention and management of fungal diseases is needed to control morbidity and mortality in the rising number of immunocompromised and at-risk patients in the United States.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab336","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T20:47:43Z","timestamp":1618606063000},"page":"309-318","source":"Crossref","is-referenced-by-count":64,"title":["Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999\u20132018"],"prefix":"10.1093","volume":"74","author":[{"given":"Emily","family":"Rayens","sequence":"first","affiliation":[{"name":"Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA"},{"name":"Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A","family":"Norris","sequence":"additional","affiliation":[{"name":"Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F","family":"Cordero","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"key":"2022012912414734800_CIT0001","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198112103052402","article-title":"An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction","volume":"305","author":"Masur","year":"1981","journal-title":"N Engl J Med"},{"key":"2022012912414734800_CIT0002","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022012912414734800_CIT0003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","article-title":"Invasive fungal infections in patients with cancer in the intensive care unit","volume":"39","author":"Sipsas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2022012912414734800_CIT0004","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar4480","article-title":"Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses","volume":"16","author":"Bishu","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2022012912414734800_CIT0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3899\/jrheum.111498","article-title":"Invasive fungal infections in patients with systemic lupus erythematosus","volume":"39","author":"Mart\u00ednez-Mart\u00ednez","year":"2012","journal-title":"J Rheumatol"},{"key":"2022012912414734800_CIT0006","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3899\/jrheum.150142","article-title":"A multicenter study of invasive fungal infections in patients with childhood-onset systemic lupus erythematosus","volume":"42","author":"Silva","year":"2015","journal-title":"J Rheumatol"},{"key":"2022012912414734800_CIT0007","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/jcm8010076","article-title":"Candida sp. infections in patients with diabetes mellitus","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J Clin Med"},{"key":"2022012912414734800_CIT0008","first-page":"296","article-title":"Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans","volume":"14","author":"Ghanaat","year":"2017","journal-title":"Clin Pract (Lond)"},{"key":"2022012912414734800_CIT0009","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.06.00074705","article-title":"The link between fungi and severe asthma: a summary of the evidence","volume":"27","author":"Denning","year":"2006","journal-title":"Eur Respir J"},{"key":"2022012912414734800_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2016.05.001","article-title":"Increased prevalence of Pneumocystis jirovecii colonisation in acute pulmonary exacerbations of cystic fibrosis","volume":"73","author":"Green","year":"2016","journal-title":"J Infect"},{"key":"2022012912414734800_CIT0011","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"key":"2022012912414734800_CIT0012","doi-asserted-by":"crossref","first-page":"e1008742","DOI":"10.1371\/journal.ppat.1008742","article-title":"Post-tuberculosis chronic pulmonary aspergillosis: an emerging public health concern","volume":"16","author":"Bongomin","year":"2020","journal-title":"PLoS Pathog"},{"key":"2022012912414734800_CIT0013","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2022012912414734800_CIT0014","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004861","article-title":"The extend of aspergillosis in critically ill patients with severe influenza pneumonia: a multicenter cohort study","author":"Coste","year":"2021","journal-title":"Crit Care Med"},{"key":"2022012912414734800_CIT0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid2701.202896","article-title":"Aspergillosis complicating severe coronavirus disease","volume":"27","author":"Marr","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022012912414734800_CIT0016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/myc.13254","article-title":"COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series","volume":"64","author":"Meijer","year":"2021","journal-title":"Mycoses"},{"key":"2022012912414734800_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"2022012912414734800_CIT0018","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.idc.2006.07.002","article-title":"Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis","volume":"20","author":"Kauffman","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"2022012912414734800_CIT0019","doi-asserted-by":"crossref","first-page":"ii27","DOI":"10.1093\/jac\/dkz041","article-title":"Diagnosis and treatment of invasive fungal infections: looking ahead","volume":"74","author":"Sanguinetti","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022012912414734800_CIT0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front Microbiol"},{"key":"2022012912414734800_CIT0021","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.chest.2019.06.032","article-title":"Advances in the diagnosis and management of invasive fungal disease","volume":"156","author":"Formanek","year":"2019","journal-title":"Chest"},{"key":"2022012912414734800_CIT0022","doi-asserted-by":"crossref","first-page":"42","DOI":"10.18869\/acadpub.cmm.1.1.42","article-title":"Pneumocystis jirovecii colonization in chronic obstructive pulmonary disease (COPD)","volume":"1","author":"Khodavaisy","year":"2015","journal-title":"Curr Med Mycol"},{"key":"2022012912414734800_CIT0023","doi-asserted-by":"crossref","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"2022012912414734800_CIT0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02088-17","article-title":"Azole resistance of environmental and clinical aspergillus fumigatus isolates from Switzerland","volume":"62","author":"Riat","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012912414734800_CIT0025","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022012912414734800_CIT0026","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"2022012912414734800_CIT0027","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997","volume":"33","author":"McNeil","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2022012912414734800_CIT0028"},{"key":"2022012912414734800_CIT0029","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022012912414734800_CIT0030","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2017.09.018","article-title":"Lower airway microbiota and mycobiota in children with severe asthma","volume":"141","author":"Goldman","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2022012912414734800_CIT0031","doi-asserted-by":"crossref","first-page":"e000842","DOI":"10.1136\/bmjresp-2020-000842","article-title":"Relationship of Pneumocystis antibody responses to paediatric asthma severity","volume":"8","author":"Rayens","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"2022012912414734800_CIT0032","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12026-011-8218-x","article-title":"Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease","volume":"50","author":"Norris","year":"2011","journal-title":"Immunol Res"},{"key":"2022012912414734800_CIT0033","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12879-017-2381-1","article-title":"Mucormycosis in renal transplant recipients: review of 174 reported cases","volume":"17","author":"Song","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2022012912414734800_CIT0034","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2022012912414734800_CIT0035","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s10096-020-03923-7","article-title":"Influenza-associated aspergillosis in critically-ill patients\u2014a retrospective bicentric cohort study","volume":"39","author":"Waldeck","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022012912414734800_CIT0036","article-title":"COVID-19 associated pulmonary aspergillosis in mechanically ventilated patients","author":"Permpalung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022012912414734800_CIT0037","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","article-title":"Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU","volume":"203","author":"Fekkar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2022012912414734800_CIT0038","doi-asserted-by":"crossref","first-page":"613774","DOI":"10.3389\/fcimb.2020.613774","article-title":"Azole resistance in aspergillus fumigatus: a five-year follow up experience in a tertiary hospital with a special focus on cystic fibrosis","volume":"10","author":"Guegan","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2022012912414734800_CIT0039","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01588-17","article-title":"Candida auris: an emerging fungal pathogen","volume":"56","author":"Spivak","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2022012912414734800_CIT0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the maps for endemic mycoses","volume":"185","author":"Ashraf","year":"2020","journal-title":"Mycopathologia"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab336\/39505738\/ciab336.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/2\/309\/42332336\/ciab336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/2\/309\/42332336\/ciab336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T12:42:32Z","timestamp":1643460152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/74\/2\/309\/6238635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,19]]},"published-print":{"date-parts":[[2022,1,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab336","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,15]]},"published":{"date-parts":[[2021,4,19]]}}}